Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanny Al-Samkari

Showing results (31-40 of 200) with videos related to

Pageof 20
Sort By:
Acta Haematologica|July 24, 2020
An Eltrombopag Red (Plasma) AlertHanny Al-Samkari, Katayoon Goodarzi
Annual Review of Pathology|September 22, 2017
Hemophagocytic LymphohistiocytosisHanny Al-Samkari, Nancy Berliner
Drugs of Today (Barcelona, Spain : 1998)|March 11, 2022
Eptacog beta, a novel recombinant factor VIIa, for the treatment of hemophiliaNathan Watson, Hanny Al-Samkari
Journal of Thrombosis and Haemostasis : JTH|March 28, 2022
A precision medicine approach to hereditary hemorrhagic telangiectasia and complex vascular anomaliesHanny Al-Samkari, Whitney Eng
Journal of Blood Medicine|August 4, 2021
Management of Adult Patients with Immune Thrombocytopenia (ITP): A Review on Current Guidance and Experience from Clinical PracticeFei Song, Hanny Al-Samkari
Platelets|February 15, 2021
Efficacy and safety evaluation of avatrombopag in immune thrombocytopenia: analyses of a phase III study and long-term extensionHanny Al-Samkari, Srikanth Nagalla
Therapeutic Advances in Hematology|April 23, 2019
Optimal use of thrombopoietin receptor agonists in immune thrombocytopeniaHanny Al-Samkari, David J Kuter
Blood Advances|November 27, 2019
Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancyHanny Al-Samkari, Jean M Connors
Blood Advances|August 27, 2024
Impact of iron overload on incidence of diabetes mellitus, cardiac disease, and death in congenital hemolytic anemiasAaron N Cheng, Hanny Al-Samkari
Haematologica|February 8, 2024
Adenovirus-associated thrombosis and thrombocytopenia: an emerging anti-PF4 disorderAndrew B Song, Hanny Al-Samkari
Pageof 20

Showing results (31-40 of 200) with videos related to

Sort By:
Pageof 20
Acta Haematologica|July 24, 2020
An Eltrombopag Red (Plasma) AlertHanny Al-Samkari, Katayoon Goodarzi
Annual Review of Pathology|September 22, 2017
Hemophagocytic LymphohistiocytosisHanny Al-Samkari, Nancy Berliner
Drugs of Today (Barcelona, Spain : 1998)|March 11, 2022
Eptacog beta, a novel recombinant factor VIIa, for the treatment of hemophiliaNathan Watson, Hanny Al-Samkari
Journal of Thrombosis and Haemostasis : JTH|March 28, 2022
A precision medicine approach to hereditary hemorrhagic telangiectasia and complex vascular anomaliesHanny Al-Samkari, Whitney Eng
Journal of Blood Medicine|August 4, 2021
Management of Adult Patients with Immune Thrombocytopenia (ITP): A Review on Current Guidance and Experience from Clinical PracticeFei Song, Hanny Al-Samkari
Platelets|February 15, 2021
Efficacy and safety evaluation of avatrombopag in immune thrombocytopenia: analyses of a phase III study and long-term extensionHanny Al-Samkari, Srikanth Nagalla
Therapeutic Advances in Hematology|April 23, 2019
Optimal use of thrombopoietin receptor agonists in immune thrombocytopeniaHanny Al-Samkari, David J Kuter
Blood Advances|November 27, 2019
Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancyHanny Al-Samkari, Jean M Connors
Blood Advances|August 27, 2024
Impact of iron overload on incidence of diabetes mellitus, cardiac disease, and death in congenital hemolytic anemiasAaron N Cheng, Hanny Al-Samkari
Haematologica|February 8, 2024
Adenovirus-associated thrombosis and thrombocytopenia: an emerging anti-PF4 disorderAndrew B Song, Hanny Al-Samkari
Pageof 20